<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Merulla, Jessica</dc:creator>
  <dc:creator>Tatiana Soldà</dc:creator>
  <dc:creator>Maurizio Molinari</dc:creator>
  <dc:date>2015-02-18</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Only native polypeptides are released from the endoplasmic reticulum (ER) to be  transported at the site of activity. Persistently misfolded proteins are retained and  eventually selected for ER-associated degradation (ERAD). The paradox of a structure- based protein quality control is that functional polypeptides may be destroyed if they are  architecturally unfit. This has health-threatening implications, as shown by the  numerous “loss-of-function” proteopathies, but also offers chances to intervene  pharmacologically to promote bypassing of the quality control inspection and export of  the mutant, yet functional protein. Here we challenged the ER of human cells with four  modular glycopolypeptides designed to alert luminal and membrane protein quality  checkpoints. Our analysis reveals the unexpected collaboration of the cytosolic AAA- ATPase p97 and the luminal quality control factor UDP-glucose:glycoprotein  glucosyltransferase (UGGT1) in a novel, BiP- and CNX-independent checkpoint. This  prevents Golgi transport of a chimera with a native ectodomain that passes the luminal  quality control scrutiny but displays an intramembrane defect. Given that human  proteopathies may result from impaired transport of functional polypeptides with minor  structural defects, identification of quality checkpoints and treatments to bypass them as  shown here upon silencing or pharmacologic inhibition of UGGT1 or p97 may have  important clinical implications.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://n2t.net/ark:/12658/srd1319008</dc:identifier>
  <dc:identifier>https://susi.usi.ch/global/documents/319008</dc:identifier>
  <dc:identifier>https://susi.usi.ch/documents/319008/files/Merulla_MBC_2015.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1091/mbc.E14-12-1615</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/ark/12658/srd1319008</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>CC BY-NC-SA</dc:rights>
  <dc:source>Molecular biology of the cell. - 2015, vol. 26, no. 8, p. 1413-1574</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">A novel UGGT1 and p97-dependent checkpoint for native ectodomains with ionizable intramembrane residue</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
